Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  UnitedHealth Group Inc    UNH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales110 618122 489130 474153 587177 127190 759
Operating income (EBITDA)10 56310 99811 75212 83814 83816 153
Operating profit (EBIT)9 2549 62310 27411 22912 92814 444
Pre-Tax Profit (EBT)8 6228 915----
Net income5 5265 6255 6196 0887 0048 024
EPS ( $)5,285,505,706,327,358,54
Dividend per Share ( $)0,801,051,411,571,651,31
Yield0,71%0,93%1,24%1,39%1,46%1,15%
Announcement Date01/17/2013
11:00am
01/16/2014
11:00am
01/21/2015
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt8 3487 6478 17013 41910 93610 346
Finance------
Operating income (EBITDA)10 56310 99811 75212 83814 83816 153
Leverage
(Debt/EBITDA)
0,79x0,70x0,70x1,05x0,74x0,64x
Capital Expenditure1 0701 1611 4471 5751 6681 595
Book Value Per Share (BVPS)30,6 $32,5 $33,7 $38,6 $42,5 $46,0 $
Cash Flow per Share6,84 $6,83 $8,16 $8,36 $9,90 $10,3 $
Announcement Date01/17/2013
11:00am
01/16/2014
11:00am
01/21/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 108 191 M$ -
Entreprise Value (EV) 121 610 M$ 119 128 M$
Valuation 2015e 2016e
PER (Price / EPS) 18,0x 15,4x
Capitalization / Revenue 0,70x 0,61x
EV / Revenue 0,79x 0,67x
EV / EBITDA 9,47x 8,03x
Yield (DPS / Price) 1,39% 1,46%
Price to book (Price / BVPS) 2,94x 2,67x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 7,31% 7,30%
operating Leverage (Delta EBIT / Delta Sales) 0,52x 0,99x
Net Margin (Net Profit / Revenue) 3,96% 3,95%
ROA (Net Profit / Asset) 6,60% 7,15%
ROE (Net Profit / Equities) 17,2% 18,0%
Rate of Dividend 24,9% 22,5%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   1,03% 0,94%
Cash Flow / Sales (Taux d'autofinancement) 5,19% 5,33%
Capital Intensity (Assets / Sales) 0,60x 0,55x
Financial Leverage (Net Debt / EBITDA) 1,05x 0,74x
Price Earning Ratio
EPS & Dividend